In SEC Filing Ackman Says Allergan is "Sandbagging"

Mark Melin

Published onAugust 14, 2014

Updated on May 13, 2021

William Ackman’s Pershing Square recently filed a Securities and Exchange Commission 14A form regarding statements he made about Allergan, Inc. (NYSE:AGN) in his recent investor letter.

Table of Contents

Ackman praises his buddy Bill Johnson for working with a cancer research firm

The SEC’s 14A form is typically used to provide shareholders information to make “informed” votes at shareholder meetings. Ackman starts this 14A, which in the title says the filing is related to Allergan, Inc. (NYSE:AGN), by taking about his old Ivy League chum, Bill Doyle, who he recruited to join Ackman at Pershing Square. Ackman makes...

Login required to continue reading.

Setup a free account to get access to this article (no credit card required).

View Full Article

Already a member? Log in here

Mark Melin

Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.

In SEC Filing Ackman Says Allergan is "Sandbagging"

Ackman praises his buddy Bill Johnson for working with a cancer research firm

Login required to continue reading.

Get Your Business News